» Articles » PMID: 35036428

A Novel Autophagy-Related Prognostic Risk Model and a Nomogram for Survival Prediction of Oral Cancer Patients

Overview
Journal Biomed Res Int
Publisher Wiley
Date 2022 Jan 17
PMID 35036428
Authors
Affiliations
Soon will be listed here.
Abstract

Background: This study is aimed at constructing a risk signature to predict survival outcomes of ORCA patients.

Methods: We identified differentially expressed autophagy-related genes (DEARGs) based on the RNA sequencing data in the TCGA database; then, four independent survival-related ARGs were identified to construct an autophagy-associated signature for survival prediction of ORCA patients. The validity and robustness of the prognostic model were validated by clinicopathological data and survival data. Subsequently, four independent prognostic DEARGs that composed the model were evaluated individually.

Results: The expressions of 232 autophagy-related genes (ARGs) in 127 ORCA and 13 control tissues were compared, and 36 DEARGs were filtered out. We performed functional enrichment analysis and constructed protein-protein interaction network for 36 DEARGs. Univariate and multivariate Cox regression analyses were adopted for searching prognostic ARGs, and an autophagy-associated signature for ORCA patients was constructed. Eventually, 4 desirable independent survival-related ARGs (, , , and ) were confirmed and comprised the prognostic model. We made use of multiple ways to verify the accuracy of the novel autophagy-related signature for survival evaluation, such as receiver-operator characteristic curve, Kaplan-Meier plotter, and clinicopathological correlational analyses. Four independent prognostic DEARGs that formed the model were also associated with the prognosis of ORCA patients.

Conclusions: The autophagy-related risk model can evaluate OS for ORCA patients independently since it is accurate and stable. Four prognostic ARGs that composed the model can be studied deeply for target treatment.

Citing Articles

Lipid Metabolism Reprogramming and Trastuzumab Resistance in Breast Cancer Cell Lines Overexpressing the ERBB2 Membrane Receptor.

Cortese K, Ponassi M, Profumo A, Vargas G, Iervasi E, Gagliani M Membranes (Basel). 2023; 13(6).

PMID: 37367744 PMC: 10304830. DOI: 10.3390/membranes13060540.


Poor Prognosis of Oral Squamous Cell Carcinoma Correlates With ITGA6.

Zhang C, Cai Q, Ke J Int Dent J. 2022; 73(2):178-185.

PMID: 35820930 PMC: 10023534. DOI: 10.1016/j.identj.2022.05.010.

References
1.
Li J, Yang D, Wang W, Piao S, Zhou J, Saiyin W . Inhibition of autophagy by 3-MA enhances IL-24-induced apoptosis in human oral squamous cell carcinoma cells. J Exp Clin Cancer Res. 2015; 34:97. PMC: 4567787. DOI: 10.1186/s13046-015-0211-0. View

2.
Klionsky D, Emr S . Autophagy as a regulated pathway of cellular degradation. Science. 2000; 290(5497):1717-21. PMC: 2732363. DOI: 10.1126/science.290.5497.1717. View

3.
Alexandra T, Marina I, Daniela M, Ioana S, Maria B, Radu R . Autophagy-A Hidden but Important Actor on Oral Cancer Scene. Int J Mol Sci. 2020; 21(23). PMC: 7729760. DOI: 10.3390/ijms21239325. View

4.
Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

5.
Avalos Y, Canales J, Bravo-Sagua R, Criollo A, Lavandero S, Quest A . Tumor suppression and promotion by autophagy. Biomed Res Int. 2014; 2014:603980. PMC: 4189854. DOI: 10.1155/2014/603980. View